Industry › BioTech

Press Releases

田中贵金属工业：对美国的医疗器械风险基金“Ambix Life Science Fund”进行出资

Sep 08, 2021 10:00 HKT/SGT

Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain

Sep 07, 2021 12:20 HKT/SGT

インテュイティブサージカル、ダビンチ手術のリモート症例見学プログラム本格運用へ

Sep 07, 2021 10:00 JST

TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund

Sep 06, 2021 10:00 HKT/SGT

New treatment option for schizophrenia Reagila(R) listed on PBS

Sep 06, 2021 06:00 HKT/SGT

New treatment option with Reagila reimbursed on the PBS Scheme

Sep 03, 2021 10:26 HKT/SGT

中基长寿科学公布2021年中期业绩

Aug 31, 2021 09:38 HKT/SGT

中基長壽科學公佈2021年中期業績

Aug 31, 2021 09:37 HKT/SGT

Zhong Ji Longevity Science Announces 2021 Interim Results

Aug 31, 2021 09:36 HKT/SGT

エーザイと富士薬品、痛風・高尿酸血症治療剤ドチヌラドについてASEAN 5ヵ国における開発・販売に関するライセンス契約を締結

Aug 31, 2021 08:50 JST

Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad in Five ASEAN Countries

Aug 31, 2021 08:42 HKT/SGT

New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin Climbs to 56.2%

Aug 21, 2021 14:02 HKT/SGT

諾輝健康發佈2021年中報業績：營收同比增長317%，毛利率攀升至56.2%

Aug 20, 2021 18:14 HKT/SGT

휴머니젠 2021년 2분기 재무 결과 보고

Aug 18, 2021 07:00 HKT/SGT

Anticancer Agent "Tazverik Tablets 200mg" (Tazemetostat Hydrobromide) Launched in Japan for EZH2 Gene Mutation-Positive Follicular Lymphoma

Aug 16, 2021 09:07 HKT/SGT

エーザイ、抗がん剤「タズベリク(R)錠200mg」（一般名：タゼメトスタット臭化水素酸塩）を日本においてEZH2遺伝子変異陽性の濾胞性リンパ腫に係る効能効果で新発売

Aug 16, 2021 09:00 JST

中基长寿科学集团积极并购及合营长寿医学业务

Aug 13, 2021 10:35 HKT/SGT

中基長壽科學集團積極併購及合營長壽醫學業務

Aug 13, 2021 10:32 HKT/SGT

東曜藥業2021年中期營業收入大幅增長78%至人民幣2,313萬元

Aug 13, 2021 09:00 HKT/SGT

TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million

Aug 13, 2021 09:00 HKT/SGT